Disc Medicine IRON EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Disc Medicine’s reported figures.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's EBITDA?
- Disc Medicine (IRON) reported EBITDA of -$69.44M in Q1 2026.
- How has Disc Medicine's EBITDA changed year-over-year?
- Disc Medicine's EBITDA decreased by 73.9% year-over-year, from -$39.93M to -$69.44M.
- What is the long-term trend for Disc Medicine's EBITDA?
- Over 3 years (2022 to 2025), Disc Medicine's EBITDA has grown at a 70.7% compound annual growth rate (CAGR), from -$47.39M to -$235.74M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.